Post in EXT] [core rigor and reproducibility (corre)] We have an RRID number

This sounds great!
See everyone next week.

On 6/25/20, 12:01 AM, "Antibody Discussion Forum on behalf of Bover,Laura"
<email obscured> on behalf of <email obscured>> wrote:

    I accepted, thanks for catching the move!

    On 6/24/20, 8:24 PM, "Antibody Discussion Forum on behalf of David Blum"
<email obscured> on behalf of <email obscured>> wrote:

        WARNING: This email originated from outside of MD Anderson. Please
validate the sender's email address before clicking on links or attachments as
they may not be safe.

        I sent out an email with the Zoom details and can add anybody else that
        responds to this thread.

        On Wed, Jun 24, 2020 at 8:04 PM Greenfield, Edward A.,Ph.D. <
        <email obscured>> wrote:

        > I would be interested.
        >
        > Best,
        > Ed.
        >
        > -----Original Message-----
        > From: Antibody Discussion Forum <email obscured>> On Behalf Of
        > David Blum
        > Sent: Wednesday, June 24, 2020 4:15 PM
        > To: <email obscured>
        > Subject: Re: [ABRF Ab Forum] FW: [EXT] Re: [core rigor and
reproducibility
        > (corre)] We have an RRID number
        >
        >         External Email - Use Caution
        >
        > Laura,
        >
        > Thanks for the note.  As a group, we haven't been active, but one
thing we
        > did was the Virtual Lab Meeting (VLM).  I would be happy to setup a
zoom
        > teleconference and anyone that would like to join could.  Perhaps the
first
        > call could be for strategic planning, discussing what we would like
to
        > accomplish then setup subsequent calls after that.  Previously the
calls
        > were held at 11am EDT to accommodate people in Europe and on the West
coast.
        >
        > Would anyone be interested in me setting up a call next Monday June
29th
        > at 11am EDT?
        >
        > On Tue, Jun 23, 2020 at 10:12 PM Bover,Laura <email obscured>>
        > wrote:
        >
        > > Dear antibody guys,
        > > I hope all of you are doing fine.
        > > We are back in business since June 16th. Not sure for how long
because
        > > Texas is raising in cases: today, Gov. Greg Abbott shared that
Texas
        > > has seen 5,000 new coronavirus cases in a single day for the first
        > > time, the numbers are moving fast in the wrong direction.
        > > Our lab works, as probably yours, based on NCI funds and program
income.
        > > Thus, as far as we can continue to work we are fine.
        > >
        > > On the other hand, this virus has made a breakthrough: everybody
        > > realize that immune system exists, and  everybody wants antibodies
        > > against everything. People that never work in antibodies titration
        > > before are titrating antibodies in plasma from recovered patients
and
        > > publishing a Preprint with one of the main figures a graph of an
        > > ELISA!! Things that we usually only mention in Mat an Meth.
        > >
        > > With all that said I proposed Frances, if you would like to meet,
once
        > > a month or once in a time, and see how are all you doing, how this
is
        > > progressing and if you have contingencies plans in case you cannot
        > > work. Or simple share a good moment, or news or papers, being the
case
        > > that one of the main treatments is so far convalescent plasma and
        > > hyperimmune polyclonal antibodies obtained and purified from
horses,
        > > recombinant from llamas and eventually cloned from single B cells
from
        > > recovered donors to use as poolsof antibodies.
        > >
        > > Approaches for vaccines developments. In fact all things that we
are
        > > the experts! Immunizing to get immune response!
        > > May be write a review, talk , etc?
        > >
        > > Also I would like to know in a personal question is, how would my
lab
        > > get a CLIA certification for making an ELISA for antibodies
titration
        > > in this case, instead than a researcher that never worked with
this,
        > > takes it as a potential result that may affect other's lives.
        > >
        > > What do you think?
        > > Can we do anything as a community of experts??
        > > Thanks!!
        > >
        > > Laura
        > > PS I would love to use zoom for these meetings and I am still
thinking
        > > why the heck I didn't invest in Zoom's stocks!!
        > >
        > > Laura Bover, PhD
        > > Professor
        > > Director Monoclonal Antibody Core Facility University of Texas
        > > M.D.Anderson Cancer Center Associate member of The University of
Texas
        > > Graduate School of Biomedical Sciences at Houston Member of the
        > > Scientific Review Committee 2 (former Clinical Research Committee
2)
        > > Member of the Steering Committee of the Immunology Program GSBS
        > > Immunology Department/ Genomics Medicine Department
        > > 7455 Fannin St Room 1SCR4.2021
        > > Houston- TX 77054
        > > T  713-563-3301 <tel:713-563-3301>
        > > F 713-563-3276 <tel:713-563-3276>
        > > <email obscured>
        > >
        > > In order to continue obtaining Core support in a challenging
        > > environment, it is crucial that our users acknowledge the following
        > > grants in all publications (see following text).  Thank you!
        > >  “We acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
        > > supported in part by CCSG grant number P30 CA016672.”
        > >
        > >
        > >
        > >
        > >
        > > On 6/23/20, 2:11 PM, "Frances Weis-Garcia" <
        > > <email obscured>> wrote:
        > >
        > >     WARNING: This email originated from outside of MD Anderson.
Please
        > > validate the sender's email address before clicking on links or
        > > attachments as they may not be safe.
        > >
        > >     I would love a monthly pow wow.
        > >     Please post to the list ... and let's see who is game.  It
think
        > > you get a few takers.
        > >
        > >
        > >     On 6/23/20, 1:07 PM, "Bover,Laura" <email obscured>>
wrote:
        > >
        > >         Hi Frances, I have just seen this email hidden under 200! I
        > > will read it and I will probably go ask with questions.
        > >         Should we organize a monthly meeting for MAbs group? Just
to
        > > exchange situations in other Cores and states and cities and
        > institutions?
        > >
        > >         One thing, I would like to know how a Core can have a
        > > certification CLIA is it is developed an assay for diagnostic.
Let's
        > > say an ELISA, is that possible?
        > >         Thanks!
        > >         Laura
        > >
        > >         On 6/2/20, 10:52 AM, "Core Rigor and Reproducibility
(CoRRe)
        > > on behalf of Frances Weis-Garcia" <email obscured> on behalf of
        > > <email obscured>> wrote:
        > >
        > >             WARNING: This email originated from outside of MD
Anderson.
        > > Please validate the sender's email address before clicking on links
or
        > > attachments as they may not be safe.
        > >
        > >             ― 1 file link ―
        > >
        > >             Found quite a few have been given for a few at MSKCC …
for
        > > example.
        > >
        > >
        > >
        > >               *   SCR_017850<
        > >
https://urldefense.com/v3/__https://scicrunch.org/resources/Any/search
        > >
?q=SCR_017850&l=SCR_017850__;!!PfbeBCCAmug!zp7khhc7NG1GfdpdSbJxcD65lI9
        > > i3lotEEL46o4XMF7Xe17We2_0sMhA716G-kwD$
        > > > - Molecular Cytogenetics Core Facility
        > >               *   SCR_017691<
        > >
https://urldefense.com/v3/__https://scicrunch.org/resources/Any/search
        > >
?q=SCR_017691&l=SCR_017691__;!!PfbeBCCAmug!zp7khhc7NG1GfdpdSbJxcD65lI9
        > > i3lotEEL46o4XMF7Xe17We2_0sMhA7_em4O2l$
        > > > - Antibody & Bioresource Core Facility
        > >               *   SCR_017853<
        > >
https://urldefense.com/v3/__https://scicrunch.org/resources/Any/search
        > >
?q=SCR_017853&l=SCR_017853__;!!PfbeBCCAmug!zp7khhc7NG1GfdpdSbJxcD65lI9
        > > i3lotEEL46o4XMF7Xe17We2_0sMhA79oyOBYh$
        > > > - Investigational Products Support Core Facility
        > >
        > >             From: Frances Weis-Garcia
<email obscured>>
        > >             Date: Tuesday, June 2, 2020 at 11:48 AM
        > >             To: "Core Rigor and Reproducibility (CoRRe)" <
        > > <email obscured>>
        > >             Subject: We have an RRID number
        > >
        > >             We have an RRID number
        > >             But cannot find other cores with RRID numbers (yet)
        > >
        > >             Only matters if we want to define the structure of the
        > > core RRID
        > >
        > >             [A screenshot of a cell phone  Description
automatically
        > > generated]
        > >
        > >             ― 1 file ―
        > >
        > >               □ image001.png  (386kb)
        > >
        > >
https://urldefense.com/v3/__http://list.abrf.org/r/file/61rKfXKRRhmceb
        > >
jVxMqaDd73I7M-1CvB-2NFYRPN/__;!!PfbeBCCAmug!zp7khhc7NG1GfdpdSbJxcD65lI
        > > 9i3lotEEL46o4XMF7Xe17We2_0sMhA7-cq3rnW$
        > >
        > >             ――
        > >             View topic
        > >
        >
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5kRaozb5cnXRgNPMB40Ica__;!!PfbeBCCAmug!zp7khhc7NG1GfdpdSbJxcD65lI9i3lotEEL46o4XMF7Xe17We2_0sMhA77Xsei7H$
        > >             Leave group
<email obscured>?Subject=Unsubscribe
        > >
        > >
        > >
        > >
        > >         The information contained in this e-mail message may be
        > > privileged, confidential, and/or protected from disclosure. This
        > > e-mail message may contain protected health information (PHI);
        > > dissemination of PHI should comply with applicable federal and
state
        > > laws. If you are not the intended recipient, or an authorized
        > > representative of the intended recipient, any further review,
        > > disclosure, use, dissemination, distribution, or copying of this
        > > message or any attachment (or the information contained therein) is
        > > strictly prohibited. If you think that you have received this
e-mail
        > > message in error, please notify the sender by return e-mail and
delete
        > > all references to it and its contents from your systems.
        > >
        > >
        > >
        > >
        > > The information contained in this e-mail message may be privileged,
        > > confidential, and/or protected from disclosure. This e-mail message
        > > may contain protected health information (PHI); dissemination of
PHI
        > > should comply with applicable federal and state laws. If you are
not
        > > the intended recipient, or an authorized representative of the
        > > intended recipient, any further review, disclosure, use,
        > > dissemination, distribution, or copying of this message or any
        > > attachment (or the information contained therein) is strictly
        > > prohibited. If you think that you have received this e-mail message
in
        > > error, please notify the sender by return e-mail and delete all
        > references to it and its contents from your systems.
        > >
        > > ――
        > > View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5bRUHLyrqMfdch3xJ1egAo__;!!PfbeBCCAmug!2d3EAC8B7PyQT72882NEfSlz9jJ9wiOKttykIhrbCNnfrrKGNVd4Nt6ZJXiz6Yu8$
        > > Leave group <email obscured>?Subject=Unsubscribe
        > >
        > >
        >
        > ――
        > View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/7efFJlkEa5AdocqXi4oNC2__;!!PfbeBCCAmug!2d3EAC8B7PyQT72882NEfSlz9jJ9wiOKttykIhrbCNnfrrKGNVd4Nt6ZJcNzU-4y$
        > Leave group <email obscured>?Subject=Unsubscribe
        >
        >
        >
        > The information in this e-mail is intended only for the person to
whom it
        > is
        > addressed. If you believe this e-mail was sent to you in error and
the
        > e-mail
        > contains patient information, please contact the Partners Compliance
        > HelpLine at
        >
https://urldefense.com/v3/__http://www.partners.org/complianceline__;!!PfbeBCCAmug!2d3EAC8B7PyQT72882NEfSlz9jJ9wiOKttykIhrbCNnfrrKGNVd4Nt6ZJc7wwkau$
. If the e-mail was sent to you in
        > error
        > but does not contain patient information, please contact the sender
and
        > properly
        > dispose of the e-mail.
        >
        > ――
        > View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/seIYKRgv7RlwME9A9WyC9__;!!PfbeBCCAmug!2d3EAC8B7PyQT72882NEfSlz9jJ9wiOKttykIhrbCNnfrrKGNVd4Nt6ZJdGdah_z$
        > Leave group <email obscured>?Subject=Unsubscribe
        >
        >

        ――
        View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5UDVSZ9IKBgdxohmZxQlwi__;!!PfbeBCCAmug!2d3EAC8B7PyQT72882NEfSlz9jJ9wiOKttykIhrbCNnfrrKGNVd4Nt6ZJfeLfkI9$
        Leave group <email obscured>?Subject=Unsubscribe




    The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

    ――
    View topic http://list.abrf.org/r/topic/3xu4fe1t9CcUWrquPBjzqY
    Leave group <email obscured>?Subject=Unsubscribe